Cargando…

Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils

Alzheimer’s disease is characterized by neuritic plaques, the main protein components of which are β-amyloid (Aβ) peptides deposited as β-sheet-rich amyloid fibrils. Cerebral Amyloid Angiopathy (CAA) consists of cerebrovascular deposits of Aβ peptides; it usually accompanies Alzheimer’s disease, tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherpelz, Kathryn P., Wang, Songlin, Pytel, Peter, Madhurapantula, Rama S., Srivastava, Atul K., Sachleben, Joseph R., Orgel, Joseph, Ishii, Yoshitaka, Meredith, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794565/
https://www.ncbi.nlm.nih.gov/pubmed/33420184
http://dx.doi.org/10.1038/s41598-020-80042-5
_version_ 1783634239346966528
author Scherpelz, Kathryn P.
Wang, Songlin
Pytel, Peter
Madhurapantula, Rama S.
Srivastava, Atul K.
Sachleben, Joseph R.
Orgel, Joseph
Ishii, Yoshitaka
Meredith, Stephen C.
author_facet Scherpelz, Kathryn P.
Wang, Songlin
Pytel, Peter
Madhurapantula, Rama S.
Srivastava, Atul K.
Sachleben, Joseph R.
Orgel, Joseph
Ishii, Yoshitaka
Meredith, Stephen C.
author_sort Scherpelz, Kathryn P.
collection PubMed
description Alzheimer’s disease is characterized by neuritic plaques, the main protein components of which are β-amyloid (Aβ) peptides deposited as β-sheet-rich amyloid fibrils. Cerebral Amyloid Angiopathy (CAA) consists of cerebrovascular deposits of Aβ peptides; it usually accompanies Alzheimer’s disease, though it sometimes occurs in the absence of neuritic plaques, as AD also occurs without accompanying CAA. Although neuritic plaques and vascular deposits have similar protein compositions, one of the characteristic features of amyloids is polymorphism, i.e., the ability of a single pure peptide to adopt multiple conformations in fibrils, depending on fibrillization conditions. For this reason, we asked whether the Aβ fibrils in neuritic plaques differed structurally from those in cerebral blood vessels. To address this question, we used seeding techniques, starting with amyloid-enriched material from either brain parenchyma or cerebral blood vessels (using meninges as the source). These amyloid-enriched preparations were then added to fresh, disaggregated solutions of Aβ to make replicate fibrils, as described elsewhere. Such fibrils were then studied by solid-state NMR, fiber X-ray diffraction, and other biophysical techniques. We observed chemical shift differences between parenchymal vs. vascular-seeded replicate fibrils in select sites (in particular, Ala2, Phe4, Val12, and Gln15 side chains) in two-dimensional (13)C-(13)C correlation solid-state NMR spectra, strongly indicating structural differences at these sites. X-ray diffraction studies also indicated that vascular-seeded fibrils displayed greater order than parenchyma-seeded fibrils in the “side-chain dimension” (~ 10 Å reflection), though the “hydrogen-bond dimensions” (~ 5 Å reflection) were alike. These results indicate that the different nucleation conditions at two sites in the brain, parenchyma and blood vessels, affect the fibril products that get formed at each site, possibly leading to distinct pathophysiological outcomes.
format Online
Article
Text
id pubmed-7794565
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77945652021-01-12 Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils Scherpelz, Kathryn P. Wang, Songlin Pytel, Peter Madhurapantula, Rama S. Srivastava, Atul K. Sachleben, Joseph R. Orgel, Joseph Ishii, Yoshitaka Meredith, Stephen C. Sci Rep Article Alzheimer’s disease is characterized by neuritic plaques, the main protein components of which are β-amyloid (Aβ) peptides deposited as β-sheet-rich amyloid fibrils. Cerebral Amyloid Angiopathy (CAA) consists of cerebrovascular deposits of Aβ peptides; it usually accompanies Alzheimer’s disease, though it sometimes occurs in the absence of neuritic plaques, as AD also occurs without accompanying CAA. Although neuritic plaques and vascular deposits have similar protein compositions, one of the characteristic features of amyloids is polymorphism, i.e., the ability of a single pure peptide to adopt multiple conformations in fibrils, depending on fibrillization conditions. For this reason, we asked whether the Aβ fibrils in neuritic plaques differed structurally from those in cerebral blood vessels. To address this question, we used seeding techniques, starting with amyloid-enriched material from either brain parenchyma or cerebral blood vessels (using meninges as the source). These amyloid-enriched preparations were then added to fresh, disaggregated solutions of Aβ to make replicate fibrils, as described elsewhere. Such fibrils were then studied by solid-state NMR, fiber X-ray diffraction, and other biophysical techniques. We observed chemical shift differences between parenchymal vs. vascular-seeded replicate fibrils in select sites (in particular, Ala2, Phe4, Val12, and Gln15 side chains) in two-dimensional (13)C-(13)C correlation solid-state NMR spectra, strongly indicating structural differences at these sites. X-ray diffraction studies also indicated that vascular-seeded fibrils displayed greater order than parenchyma-seeded fibrils in the “side-chain dimension” (~ 10 Å reflection), though the “hydrogen-bond dimensions” (~ 5 Å reflection) were alike. These results indicate that the different nucleation conditions at two sites in the brain, parenchyma and blood vessels, affect the fibril products that get formed at each site, possibly leading to distinct pathophysiological outcomes. Nature Publishing Group UK 2021-01-08 /pmc/articles/PMC7794565/ /pubmed/33420184 http://dx.doi.org/10.1038/s41598-020-80042-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Scherpelz, Kathryn P.
Wang, Songlin
Pytel, Peter
Madhurapantula, Rama S.
Srivastava, Atul K.
Sachleben, Joseph R.
Orgel, Joseph
Ishii, Yoshitaka
Meredith, Stephen C.
Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils
title Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils
title_full Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils
title_fullStr Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils
title_full_unstemmed Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils
title_short Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils
title_sort atomic-level differences between brain parenchymal- and cerebrovascular-seeded aβ fibrils
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794565/
https://www.ncbi.nlm.nih.gov/pubmed/33420184
http://dx.doi.org/10.1038/s41598-020-80042-5
work_keys_str_mv AT scherpelzkathrynp atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT wangsonglin atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT pytelpeter atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT madhurapantularamas atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT srivastavaatulk atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT sachlebenjosephr atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT orgeljoseph atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT ishiiyoshitaka atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils
AT meredithstephenc atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils